Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit

Go back to Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit
(NASDAQ: BLTE) Delayed: 138.16 +1.31 (0.96%)
Previous Close $136.85    52 Week High
Open $137.34    52 Week Low
Day High $139.00    P/E N/A 
Day Low $135.36    EPS
Volume 154,909